nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HTR2A—coronary artery disease	0.137	1	CbGaD
Paliperidone—HTR1B—Penbutolol—coronary artery disease	0.0791	0.177	CbGbCtD
Paliperidone—HTR1A—Penbutolol—coronary artery disease	0.0495	0.111	CbGbCtD
Paliperidone—CYP3A5—Clopidogrel—coronary artery disease	0.0257	0.0575	CbGbCtD
Paliperidone—CYP3A5—Eplerenone—coronary artery disease	0.0239	0.0535	CbGbCtD
Paliperidone—CYP3A5—Rosuvastatin—coronary artery disease	0.0166	0.0371	CbGbCtD
Paliperidone—CYP3A4—Ticagrelor—coronary artery disease	0.0162	0.0363	CbGbCtD
Paliperidone—CYP3A5—Simvastatin—coronary artery disease	0.0154	0.0345	CbGbCtD
Paliperidone—CYP3A5—Pravastatin—coronary artery disease	0.0151	0.0337	CbGbCtD
Paliperidone—CYP3A5—Lovastatin—coronary artery disease	0.0151	0.0337	CbGbCtD
Paliperidone—CYP3A4—Fenofibrate—coronary artery disease	0.0145	0.0324	CbGbCtD
Paliperidone—CYP3A5—Atorvastatin—coronary artery disease	0.0137	0.0307	CbGbCtD
Paliperidone—CYP3A5—Losartan—coronary artery disease	0.0126	0.0281	CbGbCtD
Paliperidone—CYP2D6—Niacin—coronary artery disease	0.0119	0.0267	CbGbCtD
Paliperidone—CYP3A4—Gemfibrozil—coronary artery disease	0.0116	0.0259	CbGbCtD
Paliperidone—CYP2D6—Timolol—coronary artery disease	0.0111	0.0249	CbGbCtD
Paliperidone—CYP3A4—Clopidogrel—coronary artery disease	0.01	0.0224	CbGbCtD
Paliperidone—CYP2D6—Captopril—coronary artery disease	0.00978	0.0219	CbGbCtD
Paliperidone—CYP2D6—Simvastatin—coronary artery disease	0.00944	0.0211	CbGbCtD
Paliperidone—CYP3A4—Eplerenone—coronary artery disease	0.00932	0.0209	CbGbCtD
Paliperidone—CYP2D6—Lovastatin—coronary artery disease	0.00924	0.0207	CbGbCtD
Paliperidone—CYP2D6—Pravastatin—coronary artery disease	0.00924	0.0207	CbGbCtD
Paliperidone—CYP2D6—Atorvastatin—coronary artery disease	0.00842	0.0188	CbGbCtD
Paliperidone—CYP3A4—Enalapril—coronary artery disease	0.0083	0.0186	CbGbCtD
Paliperidone—CYP3A4—Ezetimibe—coronary artery disease	0.00646	0.0145	CbGbCtD
Paliperidone—CYP3A4—Rosuvastatin—coronary artery disease	0.00646	0.0145	CbGbCtD
Paliperidone—CYP3A4—Simvastatin—coronary artery disease	0.006	0.0134	CbGbCtD
Paliperidone—CYP3A4—Lovastatin—coronary artery disease	0.00588	0.0132	CbGbCtD
Paliperidone—CYP3A4—Pravastatin—coronary artery disease	0.00588	0.0132	CbGbCtD
Paliperidone—CYP3A4—Atorvastatin—coronary artery disease	0.00535	0.012	CbGbCtD
Paliperidone—CYP3A4—Losartan—coronary artery disease	0.00489	0.011	CbGbCtD
Paliperidone—HTR2A—arteriole—coronary artery disease	0.00249	0.123	CbGeAlD
Paliperidone—HTR2A—pulmonary artery—coronary artery disease	0.00163	0.0805	CbGeAlD
Paliperidone—HTR2A—sympathetic nervous system—coronary artery disease	0.00159	0.0783	CbGeAlD
Paliperidone—HTR2A—vagus nerve—coronary artery disease	0.00154	0.0758	CbGeAlD
Paliperidone—HTR2A—vein—coronary artery disease	0.00149	0.0732	CbGeAlD
Paliperidone—HTR1B—artery—coronary artery disease	0.00126	0.062	CbGeAlD
Paliperidone—HTR1D—artery—coronary artery disease	0.00122	0.06	CbGeAlD
Paliperidone—DRD4—heart—coronary artery disease	0.00114	0.056	CbGeAlD
Paliperidone—HTR2A—autonomic nervous system—coronary artery disease	0.00107	0.0526	CbGeAlD
Paliperidone—Risperidone—HTR7—coronary artery disease	0.000884	0.343	CrCbGaD
Paliperidone—Iloperidone—HTR7—coronary artery disease	0.000829	0.322	CrCbGaD
Paliperidone—HTR2A—artery—coronary artery disease	0.000605	0.0298	CbGeAlD
Paliperidone—HTR2A—endothelium—coronary artery disease	0.000511	0.0252	CbGeAlD
Paliperidone—ADRA2C—cardiac ventricle—coronary artery disease	0.0005	0.0247	CbGeAlD
Paliperidone—ADRA2C—myocardium—coronary artery disease	0.000471	0.0232	CbGeAlD
Paliperidone—Risperidone—HTR2A—coronary artery disease	0.000445	0.173	CrCbGaD
Paliperidone—HTR1B—cardiovascular system—coronary artery disease	0.000437	0.0216	CbGeAlD
Paliperidone—HTR1D—cardiovascular system—coronary artery disease	0.000423	0.0209	CbGeAlD
Paliperidone—Iloperidone—HTR2A—coronary artery disease	0.000417	0.162	CrCbGaD
Paliperidone—HTR1A—cardiovascular system—coronary artery disease	0.000353	0.0174	CbGeAlD
Paliperidone—ADRA1A—heart—coronary artery disease	0.000345	0.017	CbGeAlD
Paliperidone—ADRA2C—heart—coronary artery disease	0.000328	0.0162	CbGeAlD
Paliperidone—ADRA1A—cardiovascular system—coronary artery disease	0.000325	0.016	CbGeAlD
Paliperidone—ADRA2C—cardiac atrium—coronary artery disease	0.000281	0.0138	CbGeAlD
Paliperidone—ADRA2A—heart—coronary artery disease	0.000262	0.0129	CbGeAlD
Paliperidone—ADRA1A—blood—coronary artery disease	0.000257	0.0127	CbGeAlD
Paliperidone—ADRA2C—blood—coronary artery disease	0.000245	0.0121	CbGeAlD
Paliperidone—ADRA2A—cardiac atrium—coronary artery disease	0.000224	0.011	CbGeAlD
Paliperidone—HTR2A—heart—coronary artery disease	0.000223	0.011	CbGeAlD
Paliperidone—HTR2A—cardiovascular system—coronary artery disease	0.00021	0.0104	CbGeAlD
Paliperidone—CYP3A5—blood—coronary artery disease	0.000205	0.0101	CbGeAlD
Paliperidone—ADRA2A—blood—coronary artery disease	0.000196	0.00964	CbGeAlD
Paliperidone—HTR2A—blood—coronary artery disease	0.000166	0.0082	CbGeAlD
Paliperidone—CYP3A4—blood—coronary artery disease	0.000154	0.00759	CbGeAlD
Paliperidone—CYP2D6—blood—coronary artery disease	0.000151	0.00747	CbGeAlD
Paliperidone—Asthenia—Niacin—coronary artery disease	5.03e-05	0.000207	CcSEcCtD
Paliperidone—Fatigue—Losartan—coronary artery disease	5.03e-05	0.000206	CcSEcCtD
Paliperidone—Headache—Ezetimibe—coronary artery disease	5.02e-05	0.000206	CcSEcCtD
Paliperidone—Malaise—Lisinopril—coronary artery disease	5.01e-05	0.000206	CcSEcCtD
Paliperidone—Anaphylactic shock—Ramipril—coronary artery disease	5e-05	0.000205	CcSEcCtD
Paliperidone—Oedema—Ramipril—coronary artery disease	5e-05	0.000205	CcSEcCtD
Paliperidone—Vertigo—Lisinopril—coronary artery disease	4.99e-05	0.000205	CcSEcCtD
Paliperidone—Dry mouth—Timolol—coronary artery disease	4.99e-05	0.000205	CcSEcCtD
Paliperidone—Constipation—Losartan—coronary artery disease	4.99e-05	0.000205	CcSEcCtD
Paliperidone—Pain—Losartan—coronary artery disease	4.99e-05	0.000205	CcSEcCtD
Paliperidone—Syncope—Lisinopril—coronary artery disease	4.98e-05	0.000205	CcSEcCtD
Paliperidone—Vomiting—Eplerenone—coronary artery disease	4.98e-05	0.000205	CcSEcCtD
Paliperidone—Feeling abnormal—Furosemide—coronary artery disease	4.98e-05	0.000205	CcSEcCtD
Paliperidone—Leukopenia—Lisinopril—coronary artery disease	4.97e-05	0.000204	CcSEcCtD
Paliperidone—Nausea—Fenofibrate—coronary artery disease	4.97e-05	0.000204	CcSEcCtD
Paliperidone—Pruritus—Niacin—coronary artery disease	4.96e-05	0.000204	CcSEcCtD
Paliperidone—Asthenia—Pravastatin—coronary artery disease	4.95e-05	0.000203	CcSEcCtD
Paliperidone—Gastrointestinal pain—Furosemide—coronary artery disease	4.94e-05	0.000203	CcSEcCtD
Paliperidone—Rash—Eplerenone—coronary artery disease	4.94e-05	0.000203	CcSEcCtD
Paliperidone—Urticaria—Perindopril—coronary artery disease	4.94e-05	0.000203	CcSEcCtD
Paliperidone—Hypersensitivity—Trandolapril—coronary artery disease	4.94e-05	0.000203	CcSEcCtD
Paliperidone—Dermatitis—Eplerenone—coronary artery disease	4.94e-05	0.000203	CcSEcCtD
Paliperidone—Diarrhoea—Valsartan—coronary artery disease	4.93e-05	0.000203	CcSEcCtD
Paliperidone—Confusional state—Timolol—coronary artery disease	4.93e-05	0.000202	CcSEcCtD
Paliperidone—Shock—Ramipril—coronary artery disease	4.92e-05	0.000202	CcSEcCtD
Paliperidone—Hypersensitivity—Enalapril—coronary artery disease	4.92e-05	0.000202	CcSEcCtD
Paliperidone—Abdominal pain—Perindopril—coronary artery disease	4.92e-05	0.000202	CcSEcCtD
Paliperidone—Body temperature increased—Perindopril—coronary artery disease	4.92e-05	0.000202	CcSEcCtD
Paliperidone—Palpitations—Lisinopril—coronary artery disease	4.91e-05	0.000202	CcSEcCtD
Paliperidone—Diarrhoea—Olmesartan—coronary artery disease	4.91e-05	0.000202	CcSEcCtD
Paliperidone—Headache—Eplerenone—coronary artery disease	4.91e-05	0.000202	CcSEcCtD
Paliperidone—Nervous system disorder—Ramipril—coronary artery disease	4.9e-05	0.000201	CcSEcCtD
Paliperidone—Thrombocytopenia—Ramipril—coronary artery disease	4.9e-05	0.000201	CcSEcCtD
Paliperidone—Oedema—Timolol—coronary artery disease	4.89e-05	0.000201	CcSEcCtD
Paliperidone—Anaphylactic shock—Timolol—coronary artery disease	4.89e-05	0.000201	CcSEcCtD
Paliperidone—Pruritus—Pravastatin—coronary artery disease	4.88e-05	0.000201	CcSEcCtD
Paliperidone—Loss of consciousness—Lisinopril—coronary artery disease	4.88e-05	0.000201	CcSEcCtD
Paliperidone—Nausea—Clopidogrel—coronary artery disease	4.88e-05	0.0002	CcSEcCtD
Paliperidone—Tachycardia—Ramipril—coronary artery disease	4.88e-05	0.0002	CcSEcCtD
Paliperidone—Skin disorder—Ramipril—coronary artery disease	4.86e-05	0.000199	CcSEcCtD
Paliperidone—Infection—Timolol—coronary artery disease	4.86e-05	0.000199	CcSEcCtD
Paliperidone—Vomiting—Simvastatin—coronary artery disease	4.85e-05	0.000199	CcSEcCtD
Paliperidone—Hypersensitivity—Telmisartan—coronary artery disease	4.85e-05	0.000199	CcSEcCtD
Paliperidone—Cough—Lisinopril—coronary artery disease	4.85e-05	0.000199	CcSEcCtD
Paliperidone—Nausea—Lovastatin—coronary artery disease	4.85e-05	0.000199	CcSEcCtD
Paliperidone—Rash—Simvastatin—coronary artery disease	4.81e-05	0.000198	CcSEcCtD
Paliperidone—Dermatitis—Simvastatin—coronary artery disease	4.81e-05	0.000198	CcSEcCtD
Paliperidone—Asthenia—Trandolapril—coronary artery disease	4.81e-05	0.000198	CcSEcCtD
Paliperidone—Shock—Timolol—coronary artery disease	4.81e-05	0.000198	CcSEcCtD
Paliperidone—Feeling abnormal—Losartan—coronary artery disease	4.81e-05	0.000197	CcSEcCtD
Paliperidone—Urticaria—Furosemide—coronary artery disease	4.8e-05	0.000197	CcSEcCtD
Paliperidone—Diarrhoea—Niacin—coronary artery disease	4.8e-05	0.000197	CcSEcCtD
Paliperidone—Nervous system disorder—Timolol—coronary artery disease	4.79e-05	0.000197	CcSEcCtD
Paliperidone—Asthenia—Enalapril—coronary artery disease	4.79e-05	0.000197	CcSEcCtD
Paliperidone—Headache—Simvastatin—coronary artery disease	4.78e-05	0.000196	CcSEcCtD
Paliperidone—Body temperature increased—Furosemide—coronary artery disease	4.78e-05	0.000196	CcSEcCtD
Paliperidone—Abdominal pain—Furosemide—coronary artery disease	4.78e-05	0.000196	CcSEcCtD
Paliperidone—Gastrointestinal pain—Losartan—coronary artery disease	4.77e-05	0.000196	CcSEcCtD
Paliperidone—Dizziness—Valsartan—coronary artery disease	4.77e-05	0.000196	CcSEcCtD
Paliperidone—Anorexia—Ramipril—coronary artery disease	4.77e-05	0.000196	CcSEcCtD
Paliperidone—Nausea—Ezetimibe—coronary artery disease	4.76e-05	0.000195	CcSEcCtD
Paliperidone—Skin disorder—Timolol—coronary artery disease	4.75e-05	0.000195	CcSEcCtD
Paliperidone—Dizziness—Olmesartan—coronary artery disease	4.75e-05	0.000195	CcSEcCtD
Paliperidone—Pruritus—Trandolapril—coronary artery disease	4.74e-05	0.000195	CcSEcCtD
Paliperidone—Chest pain—Lisinopril—coronary artery disease	4.73e-05	0.000194	CcSEcCtD
Paliperidone—Myalgia—Lisinopril—coronary artery disease	4.73e-05	0.000194	CcSEcCtD
Paliperidone—Arthralgia—Lisinopril—coronary artery disease	4.73e-05	0.000194	CcSEcCtD
Paliperidone—Asthenia—Telmisartan—coronary artery disease	4.72e-05	0.000194	CcSEcCtD
Paliperidone—Pruritus—Enalapril—coronary artery disease	4.72e-05	0.000194	CcSEcCtD
Paliperidone—Diarrhoea—Pravastatin—coronary artery disease	4.72e-05	0.000194	CcSEcCtD
Paliperidone—Anxiety—Lisinopril—coronary artery disease	4.71e-05	0.000194	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	4.7e-05	0.000193	CcSEcCtD
Paliperidone—Discomfort—Lisinopril—coronary artery disease	4.67e-05	0.000192	CcSEcCtD
Paliperidone—Hypotension—Ramipril—coronary artery disease	4.67e-05	0.000192	CcSEcCtD
Paliperidone—Anorexia—Timolol—coronary artery disease	4.66e-05	0.000191	CcSEcCtD
Paliperidone—Pruritus—Telmisartan—coronary artery disease	4.66e-05	0.000191	CcSEcCtD
Paliperidone—Nausea—Eplerenone—coronary artery disease	4.65e-05	0.000191	CcSEcCtD
Paliperidone—Dizziness—Niacin—coronary artery disease	4.64e-05	0.00019	CcSEcCtD
Paliperidone—Urticaria—Losartan—coronary artery disease	4.63e-05	0.00019	CcSEcCtD
Paliperidone—Dry mouth—Lisinopril—coronary artery disease	4.63e-05	0.00019	CcSEcCtD
Paliperidone—Abdominal pain—Losartan—coronary artery disease	4.61e-05	0.000189	CcSEcCtD
Paliperidone—Body temperature increased—Losartan—coronary artery disease	4.61e-05	0.000189	CcSEcCtD
Paliperidone—Asthenia—Captopril—coronary artery disease	4.59e-05	0.000189	CcSEcCtD
Paliperidone—Diarrhoea—Trandolapril—coronary artery disease	4.59e-05	0.000188	CcSEcCtD
Paliperidone—Vomiting—Valsartan—coronary artery disease	4.58e-05	0.000188	CcSEcCtD
Paliperidone—Confusional state—Lisinopril—coronary artery disease	4.57e-05	0.000188	CcSEcCtD
Paliperidone—Diarrhoea—Enalapril—coronary artery disease	4.57e-05	0.000188	CcSEcCtD
Paliperidone—Hypotension—Timolol—coronary artery disease	4.57e-05	0.000188	CcSEcCtD
Paliperidone—Dizziness—Pravastatin—coronary artery disease	4.56e-05	0.000187	CcSEcCtD
Paliperidone—Vomiting—Olmesartan—coronary artery disease	4.56e-05	0.000187	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.56e-05	0.000187	CcSEcCtD
Paliperidone—Rash—Valsartan—coronary artery disease	4.55e-05	0.000187	CcSEcCtD
Paliperidone—Dermatitis—Valsartan—coronary artery disease	4.54e-05	0.000187	CcSEcCtD
Paliperidone—Nausea—Simvastatin—coronary artery disease	4.54e-05	0.000186	CcSEcCtD
Paliperidone—Oedema—Lisinopril—coronary artery disease	4.54e-05	0.000186	CcSEcCtD
Paliperidone—Anaphylactic shock—Lisinopril—coronary artery disease	4.54e-05	0.000186	CcSEcCtD
Paliperidone—Pruritus—Captopril—coronary artery disease	4.53e-05	0.000186	CcSEcCtD
Paliperidone—Rash—Olmesartan—coronary artery disease	4.52e-05	0.000186	CcSEcCtD
Paliperidone—Insomnia—Ramipril—coronary artery disease	4.52e-05	0.000186	CcSEcCtD
Paliperidone—Dermatitis—Olmesartan—coronary artery disease	4.52e-05	0.000186	CcSEcCtD
Paliperidone—Headache—Valsartan—coronary artery disease	4.52e-05	0.000186	CcSEcCtD
Paliperidone—Diarrhoea—Telmisartan—coronary artery disease	4.51e-05	0.000185	CcSEcCtD
Paliperidone—Infection—Lisinopril—coronary artery disease	4.51e-05	0.000185	CcSEcCtD
Paliperidone—Headache—Olmesartan—coronary artery disease	4.5e-05	0.000185	CcSEcCtD
Paliperidone—Paraesthesia—Ramipril—coronary artery disease	4.49e-05	0.000184	CcSEcCtD
Paliperidone—Shock—Lisinopril—coronary artery disease	4.46e-05	0.000183	CcSEcCtD
Paliperidone—Asthenia—Perindopril—coronary artery disease	4.46e-05	0.000183	CcSEcCtD
Paliperidone—Dyspnoea—Ramipril—coronary artery disease	4.46e-05	0.000183	CcSEcCtD
Paliperidone—Vomiting—Niacin—coronary artery disease	4.46e-05	0.000183	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Timolol—coronary artery disease	4.45e-05	0.000183	CcSEcCtD
Paliperidone—Hypersensitivity—Furosemide—coronary artery disease	4.45e-05	0.000183	CcSEcCtD
Paliperidone—Somnolence—Ramipril—coronary artery disease	4.45e-05	0.000183	CcSEcCtD
Paliperidone—Thrombocytopenia—Lisinopril—coronary artery disease	4.44e-05	0.000182	CcSEcCtD
Paliperidone—Dizziness—Trandolapril—coronary artery disease	4.43e-05	0.000182	CcSEcCtD
Paliperidone—Tachycardia—Lisinopril—coronary artery disease	4.43e-05	0.000182	CcSEcCtD
Paliperidone—Insomnia—Timolol—coronary artery disease	4.42e-05	0.000182	CcSEcCtD
Paliperidone—Rash—Niacin—coronary artery disease	4.42e-05	0.000182	CcSEcCtD
Paliperidone—Dermatitis—Niacin—coronary artery disease	4.42e-05	0.000181	CcSEcCtD
Paliperidone—Dizziness—Enalapril—coronary artery disease	4.42e-05	0.000181	CcSEcCtD
Paliperidone—Skin disorder—Lisinopril—coronary artery disease	4.4e-05	0.000181	CcSEcCtD
Paliperidone—Dyspepsia—Ramipril—coronary artery disease	4.4e-05	0.000181	CcSEcCtD
Paliperidone—Pruritus—Perindopril—coronary artery disease	4.4e-05	0.000181	CcSEcCtD
Paliperidone—Headache—Niacin—coronary artery disease	4.39e-05	0.00018	CcSEcCtD
Paliperidone—Paraesthesia—Timolol—coronary artery disease	4.39e-05	0.00018	CcSEcCtD
Paliperidone—Vomiting—Pravastatin—coronary artery disease	4.39e-05	0.00018	CcSEcCtD
Paliperidone—Diarrhoea—Captopril—coronary artery disease	4.38e-05	0.00018	CcSEcCtD
Paliperidone—Dyspnoea—Timolol—coronary artery disease	4.36e-05	0.000179	CcSEcCtD
Paliperidone—Dizziness—Telmisartan—coronary artery disease	4.35e-05	0.000179	CcSEcCtD
Paliperidone—Rash—Pravastatin—coronary artery disease	4.35e-05	0.000179	CcSEcCtD
Paliperidone—Dermatitis—Pravastatin—coronary artery disease	4.35e-05	0.000179	CcSEcCtD
Paliperidone—Decreased appetite—Ramipril—coronary artery disease	4.35e-05	0.000179	CcSEcCtD
Paliperidone—Somnolence—Timolol—coronary artery disease	4.35e-05	0.000178	CcSEcCtD
Paliperidone—Asthenia—Furosemide—coronary artery disease	4.34e-05	0.000178	CcSEcCtD
Paliperidone—Headache—Pravastatin—coronary artery disease	4.32e-05	0.000178	CcSEcCtD
Paliperidone—Anorexia—Lisinopril—coronary artery disease	4.32e-05	0.000178	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Ramipril—coronary artery disease	4.32e-05	0.000177	CcSEcCtD
Paliperidone—Fatigue—Ramipril—coronary artery disease	4.31e-05	0.000177	CcSEcCtD
Paliperidone—Dyspepsia—Timolol—coronary artery disease	4.3e-05	0.000177	CcSEcCtD
Paliperidone—Hypersensitivity—Losartan—coronary artery disease	4.3e-05	0.000176	CcSEcCtD
Paliperidone—Nausea—Valsartan—coronary artery disease	4.28e-05	0.000176	CcSEcCtD
Paliperidone—Pruritus—Furosemide—coronary artery disease	4.28e-05	0.000176	CcSEcCtD
Paliperidone—Constipation—Ramipril—coronary artery disease	4.28e-05	0.000176	CcSEcCtD
Paliperidone—Nausea—Olmesartan—coronary artery disease	4.26e-05	0.000175	CcSEcCtD
Paliperidone—Vomiting—Trandolapril—coronary artery disease	4.26e-05	0.000175	CcSEcCtD
Paliperidone—Diarrhoea—Perindopril—coronary artery disease	4.25e-05	0.000175	CcSEcCtD
Paliperidone—Decreased appetite—Timolol—coronary artery disease	4.25e-05	0.000175	CcSEcCtD
Paliperidone—Vomiting—Enalapril—coronary artery disease	4.25e-05	0.000174	CcSEcCtD
Paliperidone—Hypotension—Lisinopril—coronary artery disease	4.24e-05	0.000174	CcSEcCtD
Paliperidone—Dizziness—Captopril—coronary artery disease	4.23e-05	0.000174	CcSEcCtD
Paliperidone—Rash—Trandolapril—coronary artery disease	4.23e-05	0.000174	CcSEcCtD
Paliperidone—Dermatitis—Trandolapril—coronary artery disease	4.22e-05	0.000173	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Timolol—coronary artery disease	4.22e-05	0.000173	CcSEcCtD
Paliperidone—Fatigue—Timolol—coronary artery disease	4.21e-05	0.000173	CcSEcCtD
Paliperidone—Rash—Enalapril—coronary artery disease	4.21e-05	0.000173	CcSEcCtD
Paliperidone—Dermatitis—Enalapril—coronary artery disease	4.21e-05	0.000173	CcSEcCtD
Paliperidone—Headache—Trandolapril—coronary artery disease	4.2e-05	0.000172	CcSEcCtD
Paliperidone—Vomiting—Telmisartan—coronary artery disease	4.19e-05	0.000172	CcSEcCtD
Paliperidone—Asthenia—Losartan—coronary artery disease	4.18e-05	0.000172	CcSEcCtD
Paliperidone—Headache—Enalapril—coronary artery disease	4.18e-05	0.000172	CcSEcCtD
Paliperidone—Pain—Timolol—coronary artery disease	4.18e-05	0.000172	CcSEcCtD
Paliperidone—Nausea—Niacin—coronary artery disease	4.16e-05	0.000171	CcSEcCtD
Paliperidone—Rash—Telmisartan—coronary artery disease	4.15e-05	0.000171	CcSEcCtD
Paliperidone—Dermatitis—Telmisartan—coronary artery disease	4.15e-05	0.00017	CcSEcCtD
Paliperidone—Diarrhoea—Furosemide—coronary artery disease	4.14e-05	0.00017	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	4.13e-05	0.00017	CcSEcCtD
Paliperidone—Pruritus—Losartan—coronary artery disease	4.13e-05	0.000169	CcSEcCtD
Paliperidone—Headache—Telmisartan—coronary artery disease	4.13e-05	0.000169	CcSEcCtD
Paliperidone—Feeling abnormal—Ramipril—coronary artery disease	4.12e-05	0.000169	CcSEcCtD
Paliperidone—Dizziness—Perindopril—coronary artery disease	4.11e-05	0.000169	CcSEcCtD
Paliperidone—Insomnia—Lisinopril—coronary artery disease	4.1e-05	0.000168	CcSEcCtD
Paliperidone—Nausea—Pravastatin—coronary artery disease	4.1e-05	0.000168	CcSEcCtD
Paliperidone—Gastrointestinal pain—Ramipril—coronary artery disease	4.09e-05	0.000168	CcSEcCtD
Paliperidone—Paraesthesia—Lisinopril—coronary artery disease	4.07e-05	0.000167	CcSEcCtD
Paliperidone—Vomiting—Captopril—coronary artery disease	4.07e-05	0.000167	CcSEcCtD
Paliperidone—Dyspnoea—Lisinopril—coronary artery disease	4.04e-05	0.000166	CcSEcCtD
Paliperidone—Rash—Captopril—coronary artery disease	4.04e-05	0.000166	CcSEcCtD
Paliperidone—Dermatitis—Captopril—coronary artery disease	4.03e-05	0.000166	CcSEcCtD
Paliperidone—Somnolence—Lisinopril—coronary artery disease	4.03e-05	0.000166	CcSEcCtD
Paliperidone—Feeling abnormal—Timolol—coronary artery disease	4.03e-05	0.000165	CcSEcCtD
Paliperidone—Headache—Captopril—coronary artery disease	4.01e-05	0.000165	CcSEcCtD
Paliperidone—Gastrointestinal pain—Timolol—coronary artery disease	4e-05	0.000164	CcSEcCtD
Paliperidone—Dizziness—Furosemide—coronary artery disease	4e-05	0.000164	CcSEcCtD
Paliperidone—Dyspepsia—Lisinopril—coronary artery disease	3.99e-05	0.000164	CcSEcCtD
Paliperidone—Diarrhoea—Losartan—coronary artery disease	3.99e-05	0.000164	CcSEcCtD
Paliperidone—Nausea—Trandolapril—coronary artery disease	3.98e-05	0.000164	CcSEcCtD
Paliperidone—Urticaria—Ramipril—coronary artery disease	3.97e-05	0.000163	CcSEcCtD
Paliperidone—Nausea—Enalapril—coronary artery disease	3.97e-05	0.000163	CcSEcCtD
Paliperidone—Vomiting—Perindopril—coronary artery disease	3.95e-05	0.000162	CcSEcCtD
Paliperidone—Body temperature increased—Ramipril—coronary artery disease	3.95e-05	0.000162	CcSEcCtD
Paliperidone—Abdominal pain—Ramipril—coronary artery disease	3.95e-05	0.000162	CcSEcCtD
Paliperidone—Decreased appetite—Lisinopril—coronary artery disease	3.94e-05	0.000162	CcSEcCtD
Paliperidone—Rash—Perindopril—coronary artery disease	3.92e-05	0.000161	CcSEcCtD
Paliperidone—Dermatitis—Perindopril—coronary artery disease	3.92e-05	0.000161	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.92e-05	0.000161	CcSEcCtD
Paliperidone—Nausea—Telmisartan—coronary artery disease	3.91e-05	0.000161	CcSEcCtD
Paliperidone—Fatigue—Lisinopril—coronary artery disease	3.91e-05	0.000161	CcSEcCtD
Paliperidone—Headache—Perindopril—coronary artery disease	3.9e-05	0.00016	CcSEcCtD
Paliperidone—Urticaria—Timolol—coronary artery disease	3.88e-05	0.000159	CcSEcCtD
Paliperidone—Pain—Lisinopril—coronary artery disease	3.88e-05	0.000159	CcSEcCtD
Paliperidone—Constipation—Lisinopril—coronary artery disease	3.88e-05	0.000159	CcSEcCtD
Paliperidone—Body temperature increased—Timolol—coronary artery disease	3.86e-05	0.000159	CcSEcCtD
Paliperidone—Abdominal pain—Timolol—coronary artery disease	3.86e-05	0.000159	CcSEcCtD
Paliperidone—Dizziness—Losartan—coronary artery disease	3.86e-05	0.000158	CcSEcCtD
Paliperidone—Vomiting—Furosemide—coronary artery disease	3.84e-05	0.000158	CcSEcCtD
Paliperidone—Rash—Furosemide—coronary artery disease	3.81e-05	0.000157	CcSEcCtD
Paliperidone—Dermatitis—Furosemide—coronary artery disease	3.81e-05	0.000156	CcSEcCtD
Paliperidone—Nausea—Captopril—coronary artery disease	3.8e-05	0.000156	CcSEcCtD
Paliperidone—Headache—Furosemide—coronary artery disease	3.79e-05	0.000156	CcSEcCtD
Paliperidone—Feeling abnormal—Lisinopril—coronary artery disease	3.74e-05	0.000153	CcSEcCtD
Paliperidone—Gastrointestinal pain—Lisinopril—coronary artery disease	3.71e-05	0.000152	CcSEcCtD
Paliperidone—Vomiting—Losartan—coronary artery disease	3.71e-05	0.000152	CcSEcCtD
Paliperidone—Nausea—Perindopril—coronary artery disease	3.69e-05	0.000152	CcSEcCtD
Paliperidone—Hypersensitivity—Ramipril—coronary artery disease	3.68e-05	0.000151	CcSEcCtD
Paliperidone—Rash—Losartan—coronary artery disease	3.68e-05	0.000151	CcSEcCtD
Paliperidone—Dermatitis—Losartan—coronary artery disease	3.67e-05	0.000151	CcSEcCtD
Paliperidone—Headache—Losartan—coronary artery disease	3.65e-05	0.00015	CcSEcCtD
Paliperidone—Urticaria—Lisinopril—coronary artery disease	3.6e-05	0.000148	CcSEcCtD
Paliperidone—Hypersensitivity—Timolol—coronary artery disease	3.6e-05	0.000148	CcSEcCtD
Paliperidone—Nausea—Furosemide—coronary artery disease	3.59e-05	0.000147	CcSEcCtD
Paliperidone—Asthenia—Ramipril—coronary artery disease	3.59e-05	0.000147	CcSEcCtD
Paliperidone—Abdominal pain—Lisinopril—coronary artery disease	3.59e-05	0.000147	CcSEcCtD
Paliperidone—Body temperature increased—Lisinopril—coronary artery disease	3.59e-05	0.000147	CcSEcCtD
Paliperidone—Pruritus—Ramipril—coronary artery disease	3.54e-05	0.000145	CcSEcCtD
Paliperidone—Asthenia—Timolol—coronary artery disease	3.51e-05	0.000144	CcSEcCtD
Paliperidone—Nausea—Losartan—coronary artery disease	3.46e-05	0.000142	CcSEcCtD
Paliperidone—Pruritus—Timolol—coronary artery disease	3.46e-05	0.000142	CcSEcCtD
Paliperidone—Diarrhoea—Ramipril—coronary artery disease	3.42e-05	0.000141	CcSEcCtD
Paliperidone—Diarrhoea—Timolol—coronary artery disease	3.34e-05	0.000137	CcSEcCtD
Paliperidone—Hypersensitivity—Lisinopril—coronary artery disease	3.34e-05	0.000137	CcSEcCtD
Paliperidone—Dizziness—Ramipril—coronary artery disease	3.31e-05	0.000136	CcSEcCtD
Paliperidone—Asthenia—Lisinopril—coronary artery disease	3.25e-05	0.000134	CcSEcCtD
Paliperidone—Dizziness—Timolol—coronary artery disease	3.23e-05	0.000133	CcSEcCtD
Paliperidone—Pruritus—Lisinopril—coronary artery disease	3.21e-05	0.000132	CcSEcCtD
Paliperidone—Vomiting—Ramipril—coronary artery disease	3.18e-05	0.000131	CcSEcCtD
Paliperidone—Rash—Ramipril—coronary artery disease	3.15e-05	0.000129	CcSEcCtD
Paliperidone—Dermatitis—Ramipril—coronary artery disease	3.15e-05	0.000129	CcSEcCtD
Paliperidone—Headache—Ramipril—coronary artery disease	3.13e-05	0.000129	CcSEcCtD
Paliperidone—Vomiting—Timolol—coronary artery disease	3.11e-05	0.000128	CcSEcCtD
Paliperidone—Diarrhoea—Lisinopril—coronary artery disease	3.1e-05	0.000127	CcSEcCtD
Paliperidone—Rash—Timolol—coronary artery disease	3.08e-05	0.000127	CcSEcCtD
Paliperidone—Dermatitis—Timolol—coronary artery disease	3.08e-05	0.000126	CcSEcCtD
Paliperidone—Headache—Timolol—coronary artery disease	3.06e-05	0.000126	CcSEcCtD
Paliperidone—Dizziness—Lisinopril—coronary artery disease	3e-05	0.000123	CcSEcCtD
Paliperidone—Nausea—Ramipril—coronary artery disease	2.97e-05	0.000122	CcSEcCtD
Paliperidone—Nausea—Timolol—coronary artery disease	2.9e-05	0.000119	CcSEcCtD
Paliperidone—Vomiting—Lisinopril—coronary artery disease	2.88e-05	0.000118	CcSEcCtD
Paliperidone—Rash—Lisinopril—coronary artery disease	2.86e-05	0.000117	CcSEcCtD
Paliperidone—Dermatitis—Lisinopril—coronary artery disease	2.86e-05	0.000117	CcSEcCtD
Paliperidone—Headache—Lisinopril—coronary artery disease	2.84e-05	0.000117	CcSEcCtD
Paliperidone—Nausea—Lisinopril—coronary artery disease	2.69e-05	0.000111	CcSEcCtD
Paliperidone—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	1.97e-06	1.31e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.97e-06	1.31e-05	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.96e-06	1.31e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MMP9—coronary artery disease	1.96e-06	1.31e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CTGF—coronary artery disease	1.96e-06	1.3e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.96e-06	1.3e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	1.96e-06	1.3e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.95e-06	1.3e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.95e-06	1.29e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GOT2—coronary artery disease	1.95e-06	1.29e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.94e-06	1.29e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	1.94e-06	1.29e-05	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.93e-06	1.28e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—AKT1—coronary artery disease	1.93e-06	1.28e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.93e-06	1.28e-05	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.93e-06	1.28e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	1.93e-06	1.28e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.92e-06	1.28e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.92e-06	1.28e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ALB—coronary artery disease	1.92e-06	1.28e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—AKT1—coronary artery disease	1.9e-06	1.27e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.9e-06	1.26e-05	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.89e-06	1.26e-05	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.89e-06	1.26e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.89e-06	1.26e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	1.89e-06	1.26e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	1.89e-06	1.26e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.88e-06	1.25e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.88e-06	1.25e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.88e-06	1.25e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.88e-06	1.25e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.87e-06	1.25e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.87e-06	1.25e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.87e-06	1.24e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—FGF2—coronary artery disease	1.86e-06	1.24e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.86e-06	1.24e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	1.85e-06	1.23e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	1.85e-06	1.23e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.85e-06	1.23e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.84e-06	1.23e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.84e-06	1.22e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOS3—coronary artery disease	1.84e-06	1.22e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—NOS3—coronary artery disease	1.84e-06	1.22e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.83e-06	1.22e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.83e-06	1.22e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.83e-06	1.22e-05	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.83e-06	1.22e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.83e-06	1.21e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—coronary artery disease	1.82e-06	1.21e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.82e-06	1.21e-05	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.82e-06	1.21e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	1.82e-06	1.21e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.81e-06	1.2e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.8e-06	1.2e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	1.8e-06	1.2e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.8e-06	1.2e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.8e-06	1.2e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.79e-06	1.19e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.79e-06	1.19e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.79e-06	1.19e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.79e-06	1.19e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—VEGFA—coronary artery disease	1.79e-06	1.19e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MAPK1—coronary artery disease	1.79e-06	1.19e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.78e-06	1.19e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AGT—coronary artery disease	1.78e-06	1.18e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.77e-06	1.18e-05	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	1.77e-06	1.18e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—VEGFA—coronary artery disease	1.76e-06	1.17e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.76e-06	1.17e-05	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.76e-06	1.17e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.76e-06	1.17e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.76e-06	1.17e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	1.75e-06	1.17e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.75e-06	1.17e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	1.75e-06	1.16e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.75e-06	1.16e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOE—coronary artery disease	1.74e-06	1.16e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	1.74e-06	1.16e-05	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	1.74e-06	1.16e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.73e-06	1.15e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	1.72e-06	1.15e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOA1—coronary artery disease	1.72e-06	1.15e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	1.72e-06	1.14e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.72e-06	1.14e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	1.71e-06	1.14e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.71e-06	1.14e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	1.71e-06	1.13e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.7e-06	1.13e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.7e-06	1.13e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.68e-06	1.12e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GGT1—coronary artery disease	1.68e-06	1.12e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GOT1—coronary artery disease	1.68e-06	1.12e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	1.68e-06	1.12e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.68e-06	1.11e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.66e-06	1.1e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.66e-06	1.1e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	1.66e-06	1.1e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.65e-06	1.1e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—coronary artery disease	1.64e-06	1.09e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.63e-06	1.09e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.63e-06	1.08e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	1.63e-06	1.08e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.63e-06	1.08e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—coronary artery disease	1.62e-06	1.08e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	1.61e-06	1.07e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MAPK1—coronary artery disease	1.61e-06	1.07e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	1.61e-06	1.07e-05	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.61e-06	1.07e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	1.6e-06	1.06e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.6e-06	1.06e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	1.59e-06	1.06e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.59e-06	1.06e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MAPK1—coronary artery disease	1.59e-06	1.06e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	1.58e-06	1.05e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.58e-06	1.05e-05	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.58e-06	1.05e-05	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.58e-06	1.05e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	1.58e-06	1.05e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.56e-06	1.04e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.56e-06	1.04e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.55e-06	1.03e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.55e-06	1.03e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	1.55e-06	1.03e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.55e-06	1.03e-05	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	1.55e-06	1.03e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.54e-06	1.02e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	1.53e-06	1.02e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.53e-06	1.02e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.52e-06	1.01e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	1.52e-06	1.01e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.52e-06	1.01e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—coronary artery disease	1.52e-06	1.01e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.51e-06	1e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.5e-06	9.99e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—POMC—coronary artery disease	1.5e-06	9.96e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.49e-06	9.93e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	1.49e-06	9.91e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.49e-06	9.89e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	1.49e-06	9.89e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	1.49e-06	9.89e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.48e-06	9.83e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.48e-06	9.81e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CAT—coronary artery disease	1.47e-06	9.76e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	1.46e-06	9.73e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	1.46e-06	9.71e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.46e-06	9.69e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	1.45e-06	9.62e-06	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	1.44e-06	9.55e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.43e-06	9.53e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	1.43e-06	9.53e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.43e-06	9.51e-06	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—coronary artery disease	1.43e-06	9.47e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOB—coronary artery disease	1.42e-06	9.47e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	1.42e-06	9.46e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	1.41e-06	9.4e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.41e-06	9.38e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	1.4e-06	9.33e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.4e-06	9.33e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	1.4e-06	9.28e-06	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—coronary artery disease	1.4e-06	9.28e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PIK3CA—coronary artery disease	1.39e-06	9.23e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.39e-06	9.21e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	1.39e-06	9.21e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.38e-06	9.2e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	1.38e-06	9.16e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.38e-06	9.15e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—coronary artery disease	1.37e-06	9.13e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—coronary artery disease	1.37e-06	9.08e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	1.37e-06	9.07e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—LPL—coronary artery disease	1.36e-06	9.04e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.35e-06	8.97e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	1.35e-06	8.94e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	1.34e-06	8.93e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	1.34e-06	8.9e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.33e-06	8.83e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GPX1—coronary artery disease	1.33e-06	8.82e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.32e-06	8.81e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	1.32e-06	8.76e-06	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKT1—coronary artery disease	1.31e-06	8.74e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NOS3—coronary artery disease	1.31e-06	8.69e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	1.3e-06	8.67e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	1.3e-06	8.64e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CD36—coronary artery disease	1.29e-06	8.59e-06	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKT1—coronary artery disease	1.29e-06	8.56e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.28e-06	8.48e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKT1—coronary artery disease	1.27e-06	8.42e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	1.24e-06	8.27e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.24e-06	8.23e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—coronary artery disease	1.24e-06	8.22e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.22e-06	8.14e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—coronary artery disease	1.22e-06	8.11e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.22e-06	8.1e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.22e-06	8.08e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.21e-06	8.07e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	1.21e-06	8.03e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	1.2e-06	7.98e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.2e-06	7.94e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.2e-06	7.94e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	1.19e-06	7.94e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	1.19e-06	7.93e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.19e-06	7.93e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	1.17e-06	7.78e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AGT—coronary artery disease	1.16e-06	7.74e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	7.72e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	1.14e-06	7.6e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKT1—coronary artery disease	1.14e-06	7.58e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOE—coronary artery disease	1.14e-06	7.58e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AKT1—coronary artery disease	1.13e-06	7.54e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PIK3CA—coronary artery disease	1.13e-06	7.5e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOA1—coronary artery disease	1.13e-06	7.49e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKT1—coronary artery disease	1.13e-06	7.48e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	1.11e-06	7.37e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—coronary artery disease	1.1e-06	7.32e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	1.09e-06	7.23e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—coronary artery disease	1.06e-06	7.07e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—coronary artery disease	1.06e-06	7.03e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	1.05e-06	7.01e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	1.04e-06	6.89e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.03e-06	6.88e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.03e-06	6.87e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—coronary artery disease	1.03e-06	6.84e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	1.02e-06	6.75e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	1.02e-06	6.75e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—coronary artery disease	1.01e-06	6.73e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—coronary artery disease	9.93e-07	6.6e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKT1—coronary artery disease	9.81e-07	6.52e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—POMC—coronary artery disease	9.8e-07	6.51e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKT1—coronary artery disease	9.76e-07	6.48e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	9.49e-07	6.31e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	9.44e-07	6.27e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	9.34e-07	6.21e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—coronary artery disease	9.33e-07	6.2e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AKT1—coronary artery disease	9.22e-07	6.13e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—coronary artery disease	9.18e-07	6.1e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—coronary artery disease	9.16e-07	6.09e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—coronary artery disease	8.99e-07	5.98e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—coronary artery disease	8.93e-07	5.94e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKT1—coronary artery disease	8.61e-07	5.72e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NOS3—coronary artery disease	8.54e-07	5.68e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKT1—coronary artery disease	8.47e-07	5.63e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKT1—coronary artery disease	8.45e-07	5.62e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AKT1—coronary artery disease	8.45e-07	5.61e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—coronary artery disease	8.35e-07	5.55e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	8.3e-07	5.51e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.81e-07	5.19e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	7.71e-07	5.12e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	7.35e-07	4.89e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AKT1—coronary artery disease	6.01e-07	3.99e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.81e-07	3.2e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AKT1—coronary artery disease	3.93e-07	2.61e-06	CbGpPWpGaD
